STALEVO 50/12-5/200MG 30 TAB ERITROPOYETINA 2000.00 UI PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINA

Description

PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINA

PRINCIPIO ACTIVO: HIDROSMINA

MIRCERA® 75 mcg / 0

Riesgo raro de ruptura esplénica

Cáncer colorrectal metastásico RAS tipo salvaje

STALEVO 50/12-5/200MG 30 TAB ERITROPOYETINA 2000.00 UI PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy